Impact of ivermectin drug combinations on Pediculus humanus capitis infestation in primary schoolchildren of south Indian rural villages

• Published in: International journal of dermatology 2009-11, Vol.48 (11), p.1201-1205
• Main Authors: Munirathinam, Arumugam, Sunish, Ittoop Pulikkottil, Rajendran, Rathinasamy, Tyagi, Brij Kishore
• Format: Article
• Language: English
• Subjects: Administration, Oral; Albendazole - therapeutic use; Animals; Anthelmintics - therapeutic use; Antiparasitic Agents - therapeutic use; Biological and medical sciences; Child; Dermatology; Diethylcarbamazine - therapeutic use; Drug Therapy, Combination; Endemic Diseases - statistics & numerical data; Filaricides - therapeutic use; General aspects; Humans; India; Ivermectin - therapeutic use; Lice Infestations - drug therapy; Lice Infestations - epidemiology; Lice Infestations - prevention & control; Medical sciences; Pediculus; Pediculus humanus capitis; Prevalence; Rural Population - statistics & numerical data
• ISSN: 0011-9059; 1365-4632
• DOI: 10.1111/j.1365-4632.2008.04059.x

Background  Antifilarial drug combinations including ivermectin provide antifilarial activity with ancillary benefits on intestinal helminths and ectoparasites, such as chiggers and lice. The impact of single oral dose of antifilarial drugs, viz; (1) diethylcarbamazine (DEC) alone, (ii) DEC + albendazole (ALB), (iii) ivermectin (IVR) + DEC and (iv) IVR + ALB, was determined, on the head louse (Pediculus humanus capitis) in primary school children in a rural community in south India. Methods  Primary school children (n = 534) of age 6–10 years from four villages of South India were examined for the presence of head lice before and after single dose of DEC + ivermectin drug combination. The effectiveness and the duration of cure sustained by these drugs were quantified. The head louse was examined by “combing method” during post‐treatment periods at 15, 45, 60 and 75 days interval. Results  The antifilarial drug consumption rate was similar (96–98%) in all treatment arms. In pre‐treatment survey the prevalence of head lice in children administered with DEC, DEC + ALB, IVR + DEC and IVR + ALB arm was 86%, 80%, 87% and 80%, respectively, with the latter two arms demonstrating significant reduction in louse infestation (P